Fundraise / allotmentFiled on BSE ·
Mold-Tek Technologies approves allotment of bonus shares in 1:1 ratio
What the filing says
- Board approved bonus equity shares allotment of 2,88,05,118 shares on Oct 12, 2026
- Bonus shares issued at face value Rs. 2 each to shareholders on record date Oct 9, 2026
- Paid-up equity share capital increased from Rs. 5.76 crore to Rs. 11.52 crore post allotment
Original filing
Announcement under Regulation 30 (LODR)-Allotment
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Mold-Tek Technol
- Fundraise / allotmentMold-Tek Technologies Limited announces 1:1 bonus equity share issue
- Fundraise / allotmentMold-Tek Technologies approves 1:1 bonus share issue, Record Date set Oct 09, 2026
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentMold-Tek Packaging LtdMold-Tek Packaging Limited approves allotment of bonus equity shares 1:1
- Fundraise / allotmentEmbassy Developments LtdEmbassy Developments Limited allots 3.25 crore convertible warrants on preferential basis
- Fundraise / allotmentJubilant Pharmova LtdJubilant Pharmova approves issuance of up to ₹800 crore NCDs on private placement
- Fundraise / allotmentJubilant Pharmova LtdJubilant Pharmova Limited approves issuance of up to ₹800 crore NCDs on private placement
- Fundraise / allotmentJTL Defence LtdJTL Defence Limited schedules Board Meeting on October 14, 2026 for Rights Issue approval
- Fundraise / allotmentPTC Industries LtdPTC Industries Limited allots 8,54,700 equity shares via qualified institutional placement
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.